Objective To evaluate the association between the presence of an atrial septal defect (ASD) and the odds of developing bronchopulmonary dysplasia (BPD) in premature infants.
B
ronchopulmonary dysplasia (BPD) is a major cause of morbidity and mortality, affecting 10 000-15 000 infants annually in the United States. Premature and low birth weight infants are known to be at higher risk. 1 BPD is associated with significant long-term sequelae, including chronic cardiorespiratory impairments, growth failure, and neurodevelopmental delay. 2, 3 Despite significant advances in neonatal ventilation strategies and the widespread use of antenatal steroids and postnatal surfactant, the incidence of BPD in premature infants has remained high over the past 20 years. 4 In addition to prematurity and low birth weight, possible risk factors for BPD include male sex, mechanical ventilation, higher exposure to supplemental oxygen, and the presence of a patent ductus arteriosus (PDA). 5 Up to 70% of preterm and low birth weight infants have a PDA, which results in left-to-right shunting and increased pulmonary blood flow. 6 This increased blood flow may contribute to the development of BPD by increasing alveolar and interstitial lung fluid filtration, resulting in pulmonary edema, altered respiratory mechanics, decreased lung compliance, poor gas exchange, and the need for prolonged mechanical ventilation and supplemental oxygen. 7 Left-to-right shunts are highly prevalent cardiac lesions that also include atrial septal defects (ASDs), the second most common type of congenital heart disease (CHD). 8, 9 Although an ASD is usually asymptomatic in otherwise healthy infants, the resultant increased pulmonary blood flow may hinder lung tissue development and increase a premature infant's risk of developing BPD. 10, 11 Investigators have postulated that atrial level shunts contribute to the progression of lung disease in premature infants, but this assumption is based on case reports and small single-center case series. [12] [13] [14] [15] [16] [17] [18] The extent to which an ASD affects the risk of BPD is still largely unknown. 
ORIGINAL ARTICLES
This study evaluates the association between the presence of an ASD and the odds of developing BPD in premature infants admitted to the neonatal intensive care unit (NICU). We hypothesized that, after controlling for known risk factors, the presence of an ASD would be associated with an increased odds of developing BPD.
Methods
We used an electronic health record database that prospectively captures information generated by clinicians on all infants cared for by the Pediatrix Medical Group in 228 NICUs in North America from 2004 to 2016. This information is gathered from routine clinical care documentation, including admission notes, daily progress notes, and discharge summaries. The record consists of data on multiple aspects of care, including demographics, maternal history, medications, laboratory results, diagnoses, and procedures. These data are then transferred to the Pediatrix Clinical Data Warehouse for quality improvement and research purposes. 19 We included infants with at least 1 echocardiogram performed during their hospitalization in the NICU who had a birth weight between 501 and 1249 g and a gestational age between 23 and 30 weeks to be compatible with the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network web-based BPD risk estimator. 20 We excluded outborn infants with major congenital anomalies, including heart defects other than an ASD or PDA.
We defined BPD as continuous respiratory support (supplemental oxygen, nasal cannula, high-flow nasal cannula, nasal continuous positive airway pressure, conventional mechanical ventilation, or high frequency ventilation) between 36 0/7 and 36 6/7 weeks postmenstrual age, as reported previously. 21 We defined infants as having an ASD if it was documented as a clinical diagnosis in the electronic health record. We defined PDA treatment as surgical if an infant underwent PDA ligation at any time during hospitalization. We defined PDA treatment as medical if an infant was exposed to acetaminophen or ibuprofen/indomethacin after day of life 1. This age cutoff was used to exclude courses administered as prophylaxis for the prevention of intraventricular hemorrhage. We defined postnatal steroid exposure as the use of any dexamethasone, hydrocortisone, or inhaled steroids during hospitalization. We defined postnatal diuretic exposure as the use of any diuretic (acetazolamide, amiloride, bumetanide, chlorothiazide, diazoxide, ethacrynic acid, furosemide, hydrochlorothiazide, spironolactone, or metolazone) during hospitalization. We calculated the percent of days on diuretics as the number of days with at least 1 diuretic received divided by the duration of an infant's hospitalization in days.
We extracted demographic variables-including gestational age, birth weight, race, sex, 5-minute Apgar score, type of delivery, and surfactant exposure-and the diagnoses of ASD and PDA from the data warehouse. Risk factors for BPD utilized in our study included the type of respiratory support, total ventilator days, and fraction of inspired oxygen content (FiO2). Therapeutic interventions for BPD identified and collected for our study included type of treatment for PDA, prenatal steroid exposure, postnatal steroid exposure, postnatal caffeine exposure, and postnatal diuretic exposure.
Statistical Analyses
We used frequencies (with percentages) and medians (with 25th and 75th percentiles) or means (with SDs) to describe categorical and continuous study variables, respectively. We compared the distribution of demographics, risk factors for BPD, and therapeutic interventions for BPD between infants with an ASD and those without an ASD using the c 2 test or Wilcoxon rank sum test, where appropriate.
We applied the data collected from our database in conjunction with the NICHD Neonatal Research Network BPD risk estimator to calculate an infant's predicted risk of developing mild, moderate, or severe BPD at 1, 3, 7, 14, 21, and 28 days of life. 20 The risk estimator includes birth weight, gestational age, sex, race, postnatal age, type of respiratory support, and amount of supplemental oxygen administration.
To evaluate the association between the presence of an ASD and the development of BPD, we fit separate multivariable logistic regression models with random effects for NICU site on each of the 6 postnatal days on which BPD risk was estimated. Two sets of models were built for each BPD risk severity (mild, moderate, and severe) on each of the 6 postnatal days evaluated to estimate the odds of developing BPD (for a total of 36 models). The first set (model A) adjusted for the predicted BPD risk. The second set (model B) adjusted for the predicted BPD risk and therapeutic interventions that may affect BPD risk, including surgical PDA ligation (binary variable), percent of total days on diuretics (continuous variable), any prenatal steroid exposure (binary variable), and any postnatal steroid exposure (binary variable).
To assess the robustness of our analytical method, we performed a sensitivity analysis without the NICHD Neonatal Research Network BPD risk estimations. Instead, we used logistic regression for correlated data with generalized estimating equations adjusted for demographic variables (gestational age, birth weight, sex, race) and therapeutic interventions (surgical PDA ligation, percent of total days on diuretics, prenatal steroid exposure, and postnatal steroid exposure). We report ORs with 95% CIs. We defined statistical significance at P < .05. We performed all statistical analyses using Stata 15.1 (StataCorp, College Station, Texas). This study was approved by the Duke University Institutional Review Board.
Results
We identified 20 496 infants from 228 NICUs who met study inclusion and exclusion criteria (Figure 1 ; available at www.jpeds.com). These infants had a median gestational age of 27 weeks (25th, 75th percentiles, 25, 28) and a median birth weight of 873 g (715, 1045). Of these infants, 16 000 (78%) required respiratory support with conventional mechanical ventilation or high-frequency ventilation at any time during the first 28 days of life. A total of 8892 infants (43%) were diagnosed with BPD. There were 17 209 (84%) infants with a PDA, Volume 202 • November 2018 of which 7415 (43%) were treated medically and 2945 (17%) underwent surgical ligation. We found that 17 196 infants (84%) were exposed to prenatal steroids, 7681 (37%) to postnatal steroids, and 12 307 (60%) to postnatal diuretics.
A total of 1314 infants (6%) in the study cohort were diagnosed with an ASD (Table I ) at a median postnatal age of 19 days (25th, 75th percentiles, 6, 49). These infants had a median gestational age of 27 weeks (25, 28) and a median birth weight of 885 g (725, 1060). We found that 48% of infants with an ASD versus 43% of infants without an ASD were diagnosed with BPD (P < .001). This difference was most pronounced early in the course of the study (Figure 2 ; available at www.jpeds.com).
We found that known risk factors for BPD were common in our cohort of infants (Table II) . Infants with an ASD were less likely to require invasive mechanical ventilation with conventional mechanical ventilation or high-frequency ventilation during the first 28 days of life, compared with infants without an ASD (74% vs 78%; P < .001). Infants with an ASD had a lower median FiO2 requirement and were less frequently diagnosed with a PDA compared with infants without an ASD. Both groups of infants spent a similar median number of days on a ventilator and a similar number of median days with an FiO2 requirement of greater than 21%.
Infants in our cohort were exposed to multiple interventions that may prevent or treat BPD (Table III) . Infants with an ASD were equally likely to undergo medical PDA treatment and surgical PDA ligation compared with infants without an ASD. A higher proportion of infants with an ASD were exposed to caffeine, whereas the same proportion of infants in each group was exposed to prenatal steroids, postnatal steroids, and diuretics. Infants with an ASD had a longer mean duration of exposure and higher mean percent of total days on diuretics, as compared with infants without an ASD.
The predicted probability of BPD in our cohort was high (Table IV; available at www.jpeds.com). The total number of infants decreased by the end of the risk estimation periodfrom 19 186 on day of life 1 to 18 854 on day of life 28-owing to transfer, discharge, or death. The median predicted probability of developing mild BPD was lowest on day of life 1 and greatest on day of life 21. The predicted risk of developing moderate BPD was also lowest in the immediate postnatal period and reached a peak on day of life 14. The predicted probability of developing severe BPD was highest on day of life 7, but lowest toward the end of the risk estimation period.
Adjusting for the predicted risk of BPD (model A), infants with an ASD were more likely to develop BPD compared with infants without an ASD (Figure 3) . This association was true for all postnatal ages (day 1, 3, 7, 14, 21, and 28) at the time of BPD risk prediction or predicted BPD risk severity (mild, moderate, or severe), except for mild BPD risk at postnatal ages 21 and 28 days. Adjusting for both the predicted risk of BPD and therapeutic interventions (model B), infants with an ASD Values are n (%) or mean ± SD.
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Volume 202 remained more likely to develop BPD (Figure 3) . This association was true regardless of postnatal age or the predicted BPD risk severity. The results were similar in the logistic regression for correlated data model, with a significant association between the presence of an ASD and the risk of BPD in all models, but with decreasing magnitude of the association from day of life 1 (OR, 1.37; 95% CI, 1.20-1.57) to day of life 28 (OR, 1.23; 95% CI, 1.07-1.40).
Discussion
We found that infants with an ASD had an increased odds of developing BPD after adjusting for the predicted risk of BPD as determined by the NICHD BPD risk estimator and therapeutic interventions for BPD (surgical PDA ligation, percent of total days on diuretics, prenatal steroid exposure, and postnatal steroid exposure). 20 Furthermore, the odds of developing BPD in infants with an ASD were similar regardless of postnatal age and the predicted BPD risk severity (mild, moderate, or severe). These findings suggest that the presence of an ASD may represent a previously unidentified risk factor for the development of BPD in premature infants.
BPD is the most prevalent and serious consequence of preterm birth, predisposing infants to high morbidity and mortality beyond the neonatal period. 1 Survivors of BPD are at risk for several adverse health outcomes, including chronic respiratory and cardiovascular impairments and long-term neurodevelopmental disabilities. 2 The incidence of BPD in premature and low birth weight infants has remained high over the past 2 decades. 4 This finding suggests that, despite advances in the recognition and management of BPD, underappreciated risk factors and missed opportunities for intervention likely remain.
22-24
The presence of an ASD could represent one such risk factor. Several authors have previously hypothesized that atrial level defects might contribute to the development of BPD. [12] [13] [14] [15] [16] [17] These theories are based on inferences from small single-center case series of ASD closures in former premature infants with lung disease. A multicenter prospective cohort study of 3684 premature and low birth weight infants found that those diagnosed with CHD by International Classification of Diseases, 9th edition, codes had a much higher odds of developing BPD compared with those without CHD. 25 Although 22 of the 71 infants with CHD had an ASD, the study did not assess the relative contributions of each CHD lesion to the odds of developing BPD.
The presence of an ASD leads to multiple pathologic alterations of pulmonary physiology that may predispose infants to developing BPD. First, an ASD can result in excessive pulmonary blood flow secondary to left-to-right shunting. Because premature infants possess low plasma oncotic pressure and a high capillary permeability, increased pulmonary blood flow can cause increased alveolar and interstitial fluid filtration rates, pulmonary edema, and poor pulmonary mechanics. 26, 27 Second, the transudation of plasma proteins into the lung interstitium from increased fluid filtration rates may inhibit surfactant function and increase alveolar surface tension. 28 This process can have adverse effects on alveolarization, postnatal alveolar development, and lung tissue growth. 23 Third, premature infants have poor ventricular compliance as compared with term infants. 6 Therefore, right ventricular overdistention secondary to left-to-right shunting from an ASD may impact left ventricular filling via ventricular cross-talk. This process can lead to increased left ventricular enddiastolic pressures and further contribute to pulmonary edema. Last, the exposure of underdeveloped pulmonary vessels to excessive pulmonary blood flow and the resulting increase in pressure can halt pulmonary angiogenesis and lead to vascular remodeling with intimal fibrosis and medial hypertrophy. 29, 30 These mechanisms can lead to impaired pulmonary mechanics, poor lung compliance, higher pulmonary vascular resistance, abnormal pulmonary vasoreactivity, inadequate gas exchange, and the need for prolonged mechanical ventilation and supplemental oxygen-all hallmark signs of BPD. 31 Given that an ASD is the second most prevalent congenital heart defect, targeting these mechanisms may provide immense potential for the development of novel and/or modified interventions to reduce the overall incidence of BPD in premature infants. 8, 9 Early ASD closure in premature infants maybe helpful in eliminating excessive pulmonary blood flow and halting the progression of BPD. In single-center case reports and case series, infants undergoing interventional device closure of an ASD had improved respiratory outcomes, a decreased need for mechanical ventilation, and a decreased need for diuretics. [10] [11] [12] [13] [14] [15] [16] [17] [18] A majority of these procedures were performed safely and efficaciously on former premature infants with severe BPD. However, all of these infants underwent device closure after prolonged hospitalization on mechanical respiratory support. One of the reasons for this delay was likely to allow for adequate growth to decrease the procedural risks and accommodate the size of current ASD closure devices. It is very possible that the harmful effects of left-to-right shunting on the pathogenesis of BPD had already taken place in these infants. Therefore, the development of novel ASD devices that are suitable in size for younger and smaller premature infants could have a tremendous impact on the risk of BPD. This area of research could prove to be extremely impactful, especially given that current preventative and therapeutic interventions have not shown to improve the rates of BPD. 4 The presence of an untreated ASD in premature infants at risk for BPD can result in the development of pulmonary hypertension (PH) and a higher probability of mortality. Infants with BPD have been shown to have significantly higher odds of PH compared with infants without BPD. [32] [33] [34] Furthermore, infants with both BPD and PH have almost a 5 times higher odds of mortality than those infants with BPD and no PH. [35] [36] [37] Multiple recent studies have reported that infants with BPD and atrial level shunt lesions are at an even greater risk for PH. [38] [39] [40] A single-center retrospective study of 383 preterm infants diagnosed with BPD found an almost 4-fold increased odds of PH in the atrial shunt group compared with those without an atrial shunt. 38 Additionally, a single-center prospective echocardiogram PH screening program in 159 premature and low birth weight infants with BPD found that those with PH were more than twice as likely to have an ASD. 39 The strengths of this study include its large sample size and the ability to adjust for previously described risk factors and therapeutic interventions for BPD. Our cohort included data from 228 NICUs across North America, including both academic and regional sites. It has been previously reported in a number of studies that differential NICU practices between hospitals have a significant impact on the rate of BPD occurrence in premature infants. [41] [42] [43] [44] As a result, we performed our regression analyses using random effects for NICU site to account for between-hospital variability. There are numerous risk factors that are known to alter the risk of developing BPD, including prolonged respiratory support, birth weight, gestational age, race, and sex. [45] [46] [47] [48] To account for all these relevant risk factors, we used the NICHD BPD risk estimator algorithm to calculate our cohort's predicted risk of developing mild, moderate, or severe BPD at various postnatal ages (day 1, 3, 7, 14, 21, and 28) . 20 By using these predicted values in our multivariate regression models, we were able to adjust for the variable contributions of each risk factor and their relative importance at different postnatal ages. Infants in our study were exposed to multiple interventions to prevent or treat BPD (Table III) . To ensure that these therapies did not confound the association between the presence of an ASD and the development of BPD, we accounted for surgical PDA ligation, percent of total days on diuretics, prenatal steroid exposure, and postnatal steroid use in our regression models.
The limitations of this study included those inherent to a retrospective study using a large electronic health record database. Although our data source contains a broad range of maternal and neonatal clinical variables, there may exist other unobserved risk factors that could have contributed to variability. For instance, certain characteristics of the infants' ASDs were not available from the Pediatrix database, including ASD size, location, number, hemodynamic properties, and degree/ direction of shunting. The presence of an ASD was identified solely based on clinical documentation from the electronic heath record database; therefore, we cannot verify whether the diagnosis was made based on echocardiogram reports alone.
Future studies assessing the structural and hemodynamic characteristics of a premature infant's ASD would be helpful in determining whether there is a subset of infants who would benefit from more aggressive medical or surgical treatment to halt or prevent the progression of BPD and associated PH.
In this large multicenter retrospective study, we found that premature and low birth weight infants with an ASD had increased odds of developing BPD compared with those infants without an ASD. Early therapeutic interventions in this population should be strongly considered to prevent, reverse, or stop the progression of BPD and pulmonary vascular remodeling that can lead to long-term cardiorespiratory consequences. ■ Data are median probability (25th, 75th percentiles). *Derived from the Eunice Kennedy Shriver NICHD BPD risk estimator, which includes gestational age, birth weight, race, sex, postnatal age, daily ventilator support, and highest fraction of inspired oxygen (FiO2).
